CureMeAbroad raises $1.1M pre-seed led by SteerX Ventures
CureMeAbroad has raised $1.1 million in a pre-seed round led by SteerX Ventures, with existing investor AIRA doubling down. The Bengaluru-based startup, founded in 2025 by Aditya Oza and Mikhail Bohra, is building an end-to-end platform for patients seeking healthcare across borders.
Oza previously scaled EV brand EMotorad to over $100 million in revenue, while Bohra bootstrapped Harbor365 to $10 million. The funding will support CureMeAbroad’s expansion in a market where cross-border medical travel is growing but still lacks integrated digital solutions.
The round stands out for its size in the healthtech pre-seed space, particularly in India, where recent funding activity has leaned toward AI-driven diagnostics and biotech. CureMeAbroad’s focus on patient coordination and logistics—rather than clinical innovation—positions it differently from peers like Mandrake Bio or CurvetAI, which raised pre-seed rounds in the same period.
Investor interest in medical tourism platforms has been sporadic, but the participation of SteerX Ventures, a firm with a track record in mobility and consumer tech, suggests a bet on the founders’ operational experience. How CureMeAbroad differentiates itself from traditional medical travel agencies will be key to watch.
Sources: pharmabiz.com · expresshealthcare.in
“The round signals investor confidence in end-to-end platforms for medical tourism, a niche CureMeAbroad is targeting with founders who have scaled startups before.”
Read the original reporting
The outlets below did the original reporting.
Related briefs
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.